J
Julio Rosenstock
Researcher at University of Texas Southwestern Medical Center
Publications - 423
Citations - 39792
Julio Rosenstock is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 94, co-authored 364 publications receiving 32784 citations. Previous affiliations of Julio Rosenstock include Medical City Dallas Hospital & Pfizer.
Papers
More filters
Journal ArticleDOI
Canagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
Guntram Schernthaner,Jorge Luiz Gross,Julio Rosenstock,Michael Guarisco,Min Fu,Jacqueline Yee,Masato Kawaguchi,William Canovatchel,Gary Meininger +8 more
TL;DR: Canagliflozin compared with sitagliptin for patients with type 2 diabetes and its effects on survival, morbidity and mortality are compared.
Journal ArticleDOI
Two-Year Safety and Efficacy of Inhaled Human Insulin (Exubera) in Adult Patients With Type 1 Diabetes
Julio Rosenstock,William T. Cefalu,Priscilla A. Hollander,André Bélanger,Freddy G. Eliaschewitz,Jorge Luiz Gross,Solomon S. Klioze,Lisa St Aubin,Howard Foyt,Masayo Ogawa,William T. Duggan +10 more
TL;DR: Two-year prandial EXU therapy showed a small nonprogressive difference in FEV1 and comparable sustained A1C improvement but lower FPG levels and less weight gain than seen in association with subcutaneous insulin in adults with type 2 diabetes.
Journal ArticleDOI
Initial Combination Therapy with Alogliptin and Pioglitazone in Drug-Naïve Patients With Type 2 Diabetes
Julio Rosenstock,Silvio E. Inzucchi,Jochen Seufert,Penny R. Fleck,Craig A. Wilson,Qais Mekki +5 more
TL;DR: Alogliptin plus pioglitazone combination treatment appears to be an efficacious initial therapeutic option for type 2 diabetes.
Journal ArticleDOI
Aldose reductase inhibitors and diabetic complications
Philip Raskin,Julio Rosenstock +1 more
Journal ArticleDOI
Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.
William T. Cefalu,John B. Buse,Jaakko Tuomilehto,G. Alexander Fleming,Ele Ferrannini,Hertzel C. Gerstein,Peter H. Bennett,Ambady Ramachandran,Itamar Raz,Julio Rosenstock,Steven E. Kahn +10 more
TL;DR: A Diabetes Care Editors' Expert Forum (EDF) was held in June 2015 to discuss the challenges of preventive interventions for type 2 diabetes as discussed by the authors, including how to scale up such approaches for widespread translation and implementation, how to select appropriately from various interventions and tailor them for different populations and settings, and how to ensure that preventive interventions yield clinically meaningful, cost effective outcomes.